Microinnova Featured in Chemistry Today

Redefining Agility in Pharma Manufacturing

Dr. Dirk Kirschneck shares insights on modular plant systems, AI integration, and the future of supply chain resilience in a recent panel discussion.

In the face of rising cost pressures and geopolitical shifts, the pharmaceutical manufacturing sector is undergoing a massive transformation. Dr. Dirk Kirschneck recently joined a panel of industry experts in the latest issue of Chemistry Today to outline how Microinnova envisions the future of supply chain continuity and agile production.

The discussion highlighted several key strategies for CDMOs and pharma manufacturers navigating an uncertain landscape:

• The Shift to Modular Manufacturing: Dr. Kirschneck emphasized that the traditional approach of designing process-specific plants is evolving. By composing process plants from existing modules, manufacturers can achieve a “plug and produce” agility that combines speed with high process performance. He also noted that new business models, such as plant rentals, could emerge to significantly reduce CAPEX and mitigate risk.

• Regionalization Powered by Automation: High-level automation and autonomous process plants are paving the way for regionalized manufacturing. By executing production at local sites while centralizing control and data management, companies can reduce logistical bottlenecks and boost sustainability.

• Data Exchange and AI Integration: Standardized digital development milestones are making AI tools readily applicable. Dr. Kirschneck highlighted that the future belongs to strategic, trustful partnerships where open data exchange enables deep process understanding and proactive optimizations, like predictive maintenance.

As the industry looks toward 2030, the focus will increasingly narrow to core competencies and strategic collaboration. Generating shared value from transparent data exchange will be the ultimate differentiator between industry leaders and followers.

Read now!